The Intelligent Prevention And Control System And Strategy For The Whole Disease Cycle Of Diabetic Nephropathy

Recruiting Observational Study
Diabetic Nephropathy T2DM
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
2,000 (estimated)
Sponsor
Chinese PLA General Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Diabetic nephropathy is one of the most severe microvascular complications of diabetes and a major cause of premature death and disability. It has become a leading cause of end-stage renal failure both in China and worldwide, consuming substantial medical resources. The establishment of a comprehensive regulatory system for the development and progression of diabetic nephropathy is a critical need…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
T2DM Inclusion Criteria: * Age ≥18 years old, gender is not limited * Diagnosed with type 2 diabetes * A history of type 2 diabetes for more than 5 years * Negative proteinuria * Creatinine is normal * Good compliance, voluntarily sign informed consent Exclusion Criteria: * Incomplete medical re…
Contacts

Zheyi Dong, MD

+86 13810261592

shengdai26@163.com

CONTACT